Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Will US FDA User Fee Deal Allow BsUFA Reg Science Research To Start?
Sep 23 2022
•
By
Derrick Gingery
A regulatory science research program was included in the BsUFA III agreement between the FDA and industry. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Biosimilars
More from Biosimilars & Generics